FORWARD FEATURES CALENDAR

Find us on

Latest News

The Binding Site, a specialist in protein diagnostics and a portfolio company of Nordic Capital, has appointed Mark Stevenson as its new non-executive Chairperson.  As the former Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific Inc, Stevenson will be able to draw on his extensive experience within the diagnostics and life science tools industries to support The Binding Site’s continued growth and expansion.   Thermo Fisher Scientific Inc, is a Fortune 100 company with over $40 billion in sales and a world leader in serving science through its life science solutions, analytical instruments, specialty diagnostics and laboratory
GTCR has appointed Jodi Rubenstein as the private equity firm’s new managing director, investor relations. Rubenstein comes to GTCR with more than 15 years of experience in investment management with a focus on private equity and other alternative investments.  In leading the firm’s Investor Relations function from GTCR’s Chicago offices, Rubenstein will be responsible for coordinating all of the firm’s investor relations and fundraising activities, while also serving as a senior leader contributing to the firm’s growth plan and strategy.  Rubenstein joins the firm from Goldman Sachs, where she most recently served as managing director and head of midwest private
Apart from being the top European market, the UK is also among the top five markets for  global venture capital (VC) funding activity, found GlobalData. According to the data and analytics company, a total of 1,083 VC funding deals were announced in the UK during January-July 2022 while the disclosed funding value of these deals stood at $18 billion. An analysis of GlobalData’s Financial Deals Database reveals that VC funding activity in 2022 so far has showcased a fluctuating trend in the UK with July reversing the growth trend witnessed during the previous month. The UK witnessed a 32.7% decrease
Dryad, a provider of solar-powered environmental sensor networks for ultra-early wildfire detection and forest monitoring, has closed a €10.5 million Series A funding round, led by eCAPITAL. Additional investors include Toba Capital, Semtech and Marc Benioff’s TIME Ventures.  The funding will enable the company to scale its team, accelerate its go-to-market strategy, and deliver on its mission to fight climate change and protect forests around the world.        Dryad has spent more than two years developing its end-to-end Silvanet ultra-early wildfire detection and forest monitoring system, which incorporates low-cost sensors, solar-powered LoRa® based mesh networking infrastructure and a cloud
DrinkWell, a low-calorie alcohol retailer, has secured a £1 million investment from a private investor to fuel its expansion plans. The funding will enable the Manchester-based eCommerce retailer to scale, growing its team, while investing in product development including the launch of two new brands, Lean Brew IPA and Traces Wine. In addition, DrinkWell has plans to add several new features to its retail business, expand into the European market and invest in marketing to further build its brand, plus drive recruitment, creating jobs across various areas of the business.   Over the last decade DrinkWell founder, Tom Bell, has
Pipeline Technique (PTL), a specialist in the onshore and offshore infrastructure welding, coating, and technological engineering sector, backed by private equity firm Bluewater, has acquired a trio of energy infrastructure businesses from Stanley Black & Decker.  This marks the second acquisition of 2022 for PTL – in April, the company acquired Global Project Services.   PTL, which is backed by specialist energy private equity firm Bluewater, has acquired a group of three companies from Stanley Black & Decker: CRC-Evans, Pipeline Induction Heat (PIH), and Stanley Inspection (including MicroAlloying, part of Stanley Inspection).   The acquisition creates a global specialist in
Barings has appointed Ken Griffin as the firm’s Head of Insurance Solutions, effective immediately. Griffin will be responsible for overseeing the delivery of customised solutions to meet the needs of Barings’ insurance clients globally. With a total insurance AUM of $223.3 billion, the Barings Global Insurance Solutions team harnesses a range of tools and resources across insurance portfolio management, risk management, quantitative solutions, and regulatory accounting to create client-specific solutions. Based in Charlotte, North Carolina, Griffin will report to Gordon.    Griffin has worked in the insurance and investment industries for over three decades. Prior to joining Barings, he served
Alto Capital IV, a private equity fund managed by Alto Partners, has sold its portfolio company Tricobiotos to Alfa Parf Group (Alfaparf), an Italian specialist in the professional hair care market. This is the third exit for Alto Capital IV after OFI (nutraceuticals, sold to Farmaceutici Procemsa in December 2020) and CEI Group (heavy trucks spare parts, sold to White Bridge Investments in June 2022). The average gross IRR for the first three exits is over 40% with a Fund DPI ratio of 73%. In July 2022 the fund also signed binding agreements to sell portfolio company Bia (cous cous
ArabyAds, an AdTech company in the MENA region, has raised $30 million in pre-Series B funding round from AfricInvest, a pan-African investment platform managing multiple alternative asset classes including private equity, venture capital and private credit.   ArabyAds will use the new financing to expand its footprint and further invest it to accelerate its technological advancement and talent acquisition to support the growth.    The transaction marks the eighth investment for AfricInvest’s Maghreb Private Equity Fund IV, which provides growth capital to small and mid-cap companies to expand regionally and across the African continent, spurring productivity growth and sustainable job
RiverGlade Capital (RiverGlade), a healthcare-focused private equity firm, has closed its latest fund, RiverGlade Capital Fund II (Fund II), which was over-subscribed and exceeded both its target size and initial cap with $453 million of total capital commitments.  RiverGlade’s founders have invested in healthcare services together for over 20 years and will continue to remain focused on healthcare investing in the lower middle market by partnering and supporting founders and management teams of exceptional companies that are driving outcomes for patients, providers, payors and the communities they serve. Fund II is RiverGlade’s second institutional fund, following a $325 million debut

Special Reports

Featured

Events

12 November, 2026 – 8:00 am

Directory Listings